Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 984 entries
View as:

A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

Phase: N/A Priority: Normal
NCT ID: NCT04198363 Org: User:
Start: 04/30/20 End: 11/25/21 Due: 11/25/22

Double Blind Comparative Study of TAK-875

Phase: N/A Priority: Normal
NCT ID: NCT01585792 Org: User:
Start: 05/31/12 End: 12/31/12 Due: 12/31/13

Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Phase: N/A Priority: Normal
NCT ID: NCT03138655 Org: User:
Start: 11/08/17 End: 05/26/20 Due: 05/26/21

A Survey of Lanadelumab in Participants with Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT05397431 Org: User:
Start: 05/30/22 End: 01/31/26 Due: 01/31/27

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00331487 Org: User:
Start: 09/30/00 End: 03/31/04 Due: 03/31/05

Efficacy of TAK-085 in Participants With Hypertriglyceridemia

Phase: N/A Priority: Normal
NCT ID: NCT01350973 Org: User:
Start: 11/30/09 End: 12/31/10 Due: 12/31/11

Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)

Phase: N/A Priority: Normal
NCT ID: NCT00261300 Org: User:
Start: 10/31/00 End: 07/31/08 Due: 07/31/09

Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

Phase: N/A Priority: Normal
NCT ID: NCT02151786 Org: User:
Start: 01/31/07 End: 03/31/10 Due: 03/31/11

A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Phase: N/A Priority: Normal
NCT ID: NCT05513586 Org: User:
Start: 09/13/22 End: 10/31/25 Due: 10/31/26

Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00532311 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX

Phase: N/A Priority: Normal
NCT ID: NCT05561647 Org: User:
Start: 08/01/13 End: 12/31/26 Due: 12/31/27

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Phase: N/A Priority: Normal
NCT ID: NCT02939014 Org: User:
Start: 11/07/16 End: 02/03/20 Due: 02/03/21

A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01546649 Org: User:
Start: 04/30/12 End: 12/31/14 Due: 12/31/15

A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03083639 Org: User:
Start: 03/27/17 End: 05/13/17 Due: 05/13/18

Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00957268 Org: User:
Start: 09/30/09 End: 11/30/13 Due: 11/30/14

Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02989649 Org: User:
Start: 12/22/16 End: 01/26/18 Due: 01/26/19

A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Phase: N/A Priority: Normal
NCT ID: NCT03648372 Org: User:
Start: 10/01/18 End: 12/14/23 Due: 12/14/24

A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03416374 Org: User:
Start: 02/18/18 End: 05/28/21 Due: 05/28/22

Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate

Phase: N/A Priority: Normal
NCT ID: NCT00890448 Org: User:
Start: 05/31/09 End: 05/31/10 Due: 05/31/11

A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in Portugal

Phase: N/A Priority: Normal
NCT ID: NCT06395792 Org: User:
Start: 12/01/24 End: 07/01/25 Due: 07/01/26

A Study to Collect Information of People With Narcolepsy in Spain

Phase: N/A Priority: Normal
NCT ID: NCT04667338 Org: User:
Start: 02/18/21 End: 11/04/22 Due: 11/04/23

Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02337946 Org: User:
Start: 10/16/14 End: 08/31/17 Due: 08/31/18

A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954

Phase: N/A Priority: Normal
NCT ID: NCT03277274 Org: User:
Start: 11/09/17 End: 09/10/18 Due: 09/10/19

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT01033071 Org: User:
Start: 01/31/10 End: 11/30/10 Due: 11/30/11

A Study of Teduglutide in Japanese People With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05023382 Org: User:
Start: 09/01/21 End: 02/28/26 Due: 02/28/27